Aurobindo Pharma has confirmed that its Non-Executive Director, Mr. P. Sarath Chandra Reddy, was discharged by a Special Judge in the alleged Delhi Liquor Exercise Policy case on February 27, 2026. The Court found no material evidence suggesting his participation in any conspiracy or receipt of illegal gratification. The acquittal follows extensive examination of the evidence presented by the CBI, which initiated the case via an FIR dated August 17, 2022.
Confirmation of Director’s Discharge
Aurobindo Pharma Limited issued a clarification regarding media reports concerning its Non-Executive Director, Mr. P. Sarath Chandra Reddy. The company confirms that on February 27, 2026, the Court of Sh. Jitendra Singh, Special Judge (PC Act) (CBI) -23, New Delhi, discharged Mr. Reddy, along with 22 other accused, from the proceedings related to the alleged Delhi Liquor Exercise Policy case.
Court’s Rationale for Acquittal
The discharge order, which came after two months of intense daily arguments and extensive review of evidence provided by the CBI, highlighted a significant lack of grounds for the accusation. The Court explicitly noted that there was no material demonstrating that Mr. Reddy:
- Participated in any conspiracy.
- Influenced any public servant.
- Paid or received any illegal gratification.
- Obtained any unlawful benefit related to the Delhi Liquor Policy.
The Court further stated it failed to comprehend the basis upon which Mr. Reddy was originally arrayed as Accused No. 23 in the case, referencing the 4th supplementary chargesheet filed on July 29, 2024.
Conclusion on Charges
In summary, the company states that Mr. P. Sarath Chndra Reddy has been fully discharged from the case in relation to all charges leveled by the CBI, which originated from an FIR lodged in August 2022 under various sections of the IPC and the Prevention of Corruption Act, 1988.
Source: BSE
